Altimmune (ALT) Other Non-Current Liabilities (2016 - 2025)
Historic Other Non-Current Liabilities for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $5.8 million.
- Altimmune's Other Non-Current Liabilities rose 2218846.15% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 2218846.15%. This contributed to the annual value of $5.3 million for FY2024, which is 1322500.0% up from last year.
- Per Altimmune's latest filing, its Other Non-Current Liabilities stood at $5.8 million for Q3 2025, which was up 2218846.15% from $5.4 million recorded in Q2 2025.
- In the past 5 years, Altimmune's Other Non-Current Liabilities registered a high of $7.0 million during Q3 2021, and its lowest value of $16000.0 during Q1 2025.
- Moreover, its 5-year median value for Other Non-Current Liabilities was $4.8 million (2021), whereas its average is $3.3 million.
- Per our database at Business Quant, Altimmune's Other Non-Current Liabilities crashed by 9901.48% in 2022 and then surged by 2218846.15% in 2025.
- Altimmune's Other Non-Current Liabilities (Quarter) stood at $6.1 million in 2021, then plummeted by 99.01% to $60000.0 in 2022, then crashed by 33.33% to $40000.0 in 2023, then soared by 13225.0% to $5.3 million in 2024, then rose by 8.72% to $5.8 million in 2025.
- Its Other Non-Current Liabilities was $5.8 million in Q3 2025, compared to $5.4 million in Q2 2025 and $16000.0 in Q1 2025.